MCP110

CAS No. 521310-51-0

MCP110( MCP 110 )

Catalog No. M14832 CAS No. 521310-51-0

MCP110 is a potent Ras/Raf-1 interaction inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 147 In Stock
10MG 258 In Stock
25MG 460 In Stock
50MG 668 In Stock
100MG 888 In Stock
500MG 1782 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MCP110
  • Note
    Research use only, not for human use.
  • Brief Description
    MCP110 is a potent Ras/Raf-1 interaction inhibitor.
  • Description
    MCP110 is a potent Ras/Raf-1 interaction inhibitor; inhibits Ras-induced Raf-1 activation in human embryonic kidney 293 cells, Raf-1 and MAPK1 activities in HT1080 fibrosarcoma cells, and EGF-induced Raf-1 activation in A549 lung carcinoma cells; inhibits anchorage-independent growth of A549 and PANC-1 cells harboring K-ras mutation; causes G1 enrichment of A549 cells with the decrease of cyclin D level; inhibits the growth of LXFA 629 lung and SW620 colon carcinoma cells in xenograft models.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MCP 110
  • Pathway
    MAPK/ERK Signaling
  • Target
    Raf
  • Recptor
    Raf
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    521310-51-0
  • Formula Weight
    508.662
  • Molecular Formula
    C33H36N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (491.50 mM)
  • SMILES
    COC(C=C(CN(C(CCCCC1=CC=CC=C1)=O)CCC2=CC=CC=N2)C=C3)=C3OCC4=CC=CC=C4
  • Chemical Name
    N-[[3-Methoxy-4-(phenylmethoxy)phenyl]methyl]-N-[2-(2-pyridinyl)ethyl]benzenepentanamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kato-Stankiewicz J, et al. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14398-403. 2. Skobeleva N, et al. Mol Cancer Ther. 2007 Mar;6(3):898-906. 3. González-Pérez V, et al. J Mol Signal. 2010 Feb 23;5:2.
molnova catalog
related products
  • Dabrafenib

    Dabrafenib (GSK2118436) is a mutant BRAFV600 specific inhibitor with IC50 of 0.8 nM in cell-free assays, with 4- and 6-fold less potency against B-Raf(wt) and c-Raf, respectively.

  • LY3009120

    LY3009120 (DP-4978) is a potent pan-RAF and RAF dimer inhibitor with IC50 of 5.8, 9.1 and 15 nM for BRAF V600E, BRAF WT and CRAF WT, respectively.

  • CCT241161

    CCT241161 is a potent pan-RAF inhibitor with IC50 of 30, 15 and 6 nM for BRAF, V600E-BRAF and C-RAF.